I’d argue it is a pair of biotech ETFs that spread their risk, but not too much, while offering a piece of the next ...

The evidence is crystal clear: the largest barrier to Alzheimer’s treatment in Latino communities is the stigma associated with cognitive decline.

September 2025 - PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations.

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years.

At what time of the day you eat strongly shapes which bacteria thrives in your gut and what they produce. Lets understand why ...

The American pharma giant Merck, known as MSD in the rest of the world, announced plans to move its life sciences research ...

September 2025 - PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations. Reference is made to the announcement on 18th August 2025 regarding ...

Study shows chatbots cite recent, authoritative health sources, but models differ in credibility and media reliance.

Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why ...

Considering the fast-paced and stressful lives most people live, Diabetes has become a major lifestyle diseases affecting ...

As U.S. pharma braces for a $236B patent cliff, Chinese biotech surges—and EquitiesFirst unlocks capital with equity-backed ...

Skye Bioscience is rated Buy, driven by nimacimab’s strong safety, durable weight-loss profile, and upcoming Phase 2a results ...